AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$HUM

Humana: Q3 Earnings Snapshot

Humana Inc. (HUM) reported Q3 net income of $162M, or $1.33 per share, beating estimates. Adjusted losses were 70 cents per share. Revenue was $41.16B, also exceeding forecasts. The company expects full-year earnings of $9.50 per share.

Original reporting
finance.yahoo.com
Published Nov 6, 2026, 11:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 11:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Humana: Q3 Earnings Snapshot — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$HUMBullishHigh
01

Why it matters

Earnings beat may trigger short-term buying and raise expectations for FY guidance.

02

Market read

First-report earnings with a sizable beat; relevant for traders targeting health insurance stocks.

03

What to watch

Potential headwinds from healthcare cost pressures not addressed in the release.

Relevance 8/10Novelty 8/10Timing: after-market Friday

Background

Humana is a major U.S. health insurer; earnings season often moves the sector.

Company-level read

Ticker impact

$HUMBullishHigh confidence
Context

Humana reported Q3 earnings beating expectations with $41.16B revenue and $1.33 EPS.

Expected impact

likely upward pressure as market prices in the earnings beat

Evidence & confidence

Beat of both earnings and revenue versus Zacks consensus suggests positive sentiment and potential buying interest.

Market effects

Sector

Health insurance sector may see modest lift from strong earnings.

Regional

U.S. market participants may adjust exposure to insurers.

Global

Limited to U.S. equities; no direct global impact.

Counterpoint

What could challenge this read

If guidance for full-year EPS of $9.50 is seen as modest, the stock could face downside.

Key entities

  • company
    Humana Inc.

    U.S. health insurer reporting Q3 results.

Read at source← All news

StoryHumana posts Q3 2026 results and lifts FY2026 adjusted EPS guidance to at least $9.50

Also covered by

6 outlets

Related articles

$HUMHighAI 8/10

Humana Raises Profit Floor on Lower Costs

Humana (HUM) raised its 2026 adjusted earnings guidance to at least $9.50 per share from $9.00, citing lower costs. Q3 insurance benefit ratio was 93.7%, better than expected. Shares fell 0.59% in pre-market trading. Humana's Medicare Advantage membership grew 23% this year.

asktraders.com
$HUMHighAI 8/10

HUM Q3 FY2026 earnings call

Humana Inc. reported Q3 2026 earnings exceeding expectations, raising full-year adjusted EPS guidance to at least $9.50. The company cited favorable medical cost trends and strong execution. Management highlighted progress in clinical quality, Medicaid expansion, and capital allocation, including a divestiture and a new joint venture. Humana expects 2027 Medicare Advantage membership growth and an 8%-9% medical cost trend, with risks and opportunities outlined.

finance.biggo.com
$HUMHighAI 8/10

[Humana Q3 2026 Earnings Call] Humana Lifts Full-Year EPS Guidance to at Least $9.50 as Medical Cost Trend Lands at Low End of 7%-8% Range

Humana Inc. raised its full-year 2026 adjusted EPS guidance to at least $9.50 per share from $9.00, citing favorable medical cost trends. The company reported strong STARS performance and plans to use excess funds for investments and shareholder returns. Humana also announced balance sheet improvements through divestitures and a new joint venture with BlackRock. Management expects 2027 Medicare Advantage membership growth and higher medical cost trends.

finance.biggo.com
$HUMMed

Humana Lifted Its Profit Forecast As Medical Costs Cooled

Humana raised its profit forecast due to lower medical costs, despite posting an adjusted quarterly loss. The company reported a 93.7% medical cost ratio, which may influence its Medicare Advantage pricing. Humana's individual Medicare Advantage membership grew 23% year-to-date, with a target of 25% growth by 2026 and a pretax margin of at least 3% by 2028.

finimize.com